Top

Reactions Weekly

Published in:

01-06-2023 | Daratumumab | Case report

Antineoplastics

Various toxicity and lack of efficacy: 2 case reports

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Stork M. Ixazomib - lenalidomide - dexamethason in heavily pretreated multiple myeloma patients - case reports. Klinicka Onkologie 36: 150-154, No. 2, Jan 2023. Available from: URL: http://doi.org/10.48095/ccko2023150 [Czech; summarised from a translation]

Title: Antineoplastics
Various toxicity and lack of efficacy: 2 case reports
Publication date: 01-06-2023
Publisher: Springer International Publishing
Keywords: Daratumumab
Multiple Myeloma
Stem Cell Transplantation
Stem Cell Transplantion
Stem Cell Transplantation
Neutropenia
Pneumonia
Dexamethasone
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-41725-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Antineoplastics

Various toxicity and lack of efficacy: 2 case reports

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Padsevonil

Tozinameran

Clonazepam/corticotropin

Elasomeran/tozinameran

Amiodarone/baricitinib/favipiravir

Elasomeran/tozinameran